C19H17N9O6S2 — CID 135515255
(6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-hydroxyiminoacetyl]amino]-3-[(6-methoxyimidazo[1,2-b]pyridazin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (PubChem CID 135515255) has the molecular formula C19H17N9O6S2 and a molecular weight of 531.54 g/mol. Its IUPAC name is (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-hydroxyiminoacetyl]amino]-3-[(6-methoxyimidazo[1,2-b]pyridazin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate.
| Compound Name | (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-hydroxyiminoacetyl]amino]-3-[(6-methoxyimidazo[1,2-b]pyridazin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|---|---|
| PubChem CID | 135515255 |
| Molecular Formula | C19H17N9O6S2 |
| Molecular Weight | 531.54 g/mol |
| Exact Mass | 531.07 |
| IUPAC Name | (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-hydroxyiminoacetyl]amino]-3-[(6-methoxyimidazo[1,2-b]pyridazin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
| SMILES | COc1ccc2n(cc[n+]2CC2=C(C(=O)[O-])N3C(=O)[C@@H](NC(=O)/C(=N\O)c4nsc(N)n4)[C@H]3SC2)n1 |
| InChI | InChI=1S/C19H17N9O6S2/c1-34-9-2-3-10-26(4-5-27(10)23-9)6-8-7-35-17-12(16(30)28(17)13(8)18(31)32)21-15(29)11(24-33)14-22-19(20)36-25-14/h2-5,12,17H,6-7H2,1H3,(H4-,20,21,22,25,29,31,32,33)/t12-,17-/m1/s1 |
| InChIKey | NFQCWSPMDUYCKY-SJKOYZFVSA-N |
| XLogP | -2.65 |
| TPSA | 204.34 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 36 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 531.54 |
| LogP ≤ 5 | -2.65 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 14 |
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'oxime_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|